Skip to main content

Cingulate Therapeutics

Morristown, United States

Cingulate Therapeutics uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.

$12.0M raised
Feb 2026
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cingulate Therapeutics

How much funding has Cingulate Therapeutics raised?
Cingulate Therapeutics has raised $12.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2026.
Who are Cingulate Therapeutics's investors?
Cingulate Therapeutics's investors include Werth Ventures, Lincoln Park Capital Fund, Falcon Creek Capital Advisor, Jeff Hargroves.
Where is Cingulate Therapeutics headquartered?
Cingulate Therapeutics is headquartered in Morristown, United States.
What does Cingulate Therapeutics do?
Cingulate Therapeutics uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.
What stage is Cingulate Therapeutics at?
Cingulate Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cingulate Therapeutics — Funding & Investors." VCBacked, February 17, 2026, https://www.vcbacked.co/company/cingulate-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Cingulate Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cingulate-therapeutics
Wikipedia (cite web)
{{cite web |title=Cingulate Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cingulate-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .